Latest Period
Q1 2026
Security Snapshot
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) Institutional Ownership
CUSIP: 004468500
13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026
Institutions Reporting
79
Shares (Excl. Options)
21,523,954
Price
$2.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- ACHV on Nasdaq
- Shares outstanding
- 102,729,871
- Price per share
- $4.27
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 21,523,954
- Total reported value
- $63,555,449
- % of total 13F portfolios
- 0%
- Share change
- -1,614,690
- Value change
- -$6,062,639
- Number of holders
- 79
- Price from insider filings
- $4.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 004468500.
- 79 institutions reported positions in Q1 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 77 to 79 between Q4 2025 and Q1 2026.
- Reported value moved from $115,291,318 to $63,555,449.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 79 institutions filings for Q1 2026.
Security key
004468500
Latest holder period
Q1 2026
13F holders
79
13D/G owners
10
CIK / CUSIP context first
Open Q1 2026 holders
ACHV full holder history
ACHIEVE LIFE SCIENCES, INC. SEC filings
ACHIEVE LIFE SCIENCES, INC. company facts
ACHIEVE LIFE SCIENCES, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 004468500:
Significant Owners of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 13% | $40,440,170 | 13,755,160 | TPG GP A, LLC | 17 Apr 2025 | |||
| venBio Global Strategic Fund V, L.P. | 10% | $31,567,712 | 10,737,317 | venBio Global Strategic Fund V, L.P. | 15 Apr 2026 | |||
| Paradigm Biocapital Advisors LP | 9.2% | $29,116,913 | 9,903,712 | Paradigm BioCapital Advisors LP | 17 Apr 2026 | |||
| Frazier Life Sciences Public Fund, L.P. | 6.5% | $19,479,817 | 6,625,788 | Frazier Life Sciences Public Fund, L.P. | 17 Apr 2026 | |||
| FRANKLIN RESOURCES INC | 6.2% | -44% | $22,801,922 | +$211 | 6,369,252 | +0% | Franklin Resources, Inc. | 30 Apr 2026 |
| Venrock Healthcare Capital Partners III, L.P. | 5.2% | $16,176,068 | 5,502,064 | Venrock Healthcare Capital Partners III, L.P. | 17 Apr 2026 | |||
| Alyeska Investment Group, L.P. | 5.6% | -43% | $9,395,574 | -$6,098,715 | 2,982,722 | -39% | Alyeska Investment Group, L.P. | 30 Sep 2025 |
| Contrarian Alpha, LP | 4.9% | $7,964,388 | 2,528,377 | Parker Quillen | 30 Sep 2025 | |||
| VANGUARD GROUP INC | 5% | $4,086,493 | 1,717,014 | The Vanguard Group | 31 Mar 2025 | |||
| BlackRock, Inc. | 0.6% | $711,220 | 314,699 | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Mar 2026, 79 institutional investors reported holding 21,523,954 shares of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV). This represents 21% of the company’s total 102,729,871 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 4.3% | 4,369,193 | 0% | 0% | $12,845,427 |
| Propel Bio Management, LLC | 3.7% | 3,786,425 | 0% | 7.2% | $11,368,992 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1% | 2,204,714 | 0% | 0% | $6,481,859 |
| Simplify Asset Management Inc. | 1.2% | 1,184,512 | 0% | 0.05% | $3,482,465 |
| MILLENNIUM MANAGEMENT LLC | 1% | 1,077,338 | -21% | 0% | $3,167,374 |
| MARSHALL WACE, LLP | 0.99% | 1,019,281 | 0% | 0% | $2,996,686 |
| LPL Financial LLC | 0.71% | 728,448 | +15% | 0% | $2,141,637 |
| Nantahala Capital Management, LLC | 0.63% | 648,885 | 0% | 0.12% | $1,907,722 |
| RAYMOND JAMES FINANCIAL INC | 0.62% | 641,925 | +7% | 0% | $1,887,259 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.61% | 622,785 | +3.9% | 0% | $1,831,935 |
| TWO SIGMA INVESTMENTS, LP | 0.57% | 588,551 | -21% | 0% | $1,730,340 |
| KVP Capital Advisors, LP | 0.45% | 462,355 | 0% | 1% | $1,359,324 |
| BlackRock, Inc. | 0.43% | 439,360 | +4.8% | 0% | $1,291,718 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.37% | 383,683 | -23% | 0% | $1,128,028 |
| UBS Group AG | 0.32% | 326,270 | +14% | 0% | $959,234 |
| VANGUARD FIDUCIARY TRUST CO | 0.31% | 316,177 | 0% | 0% | $929,560 |
| STATE STREET CORP | 0.25% | 254,457 | +8.6% | 0% | $748,104 |
| NORTHERN TRUST CORP | 0.22% | 224,742 | -2.2% | 0% | $660,741 |
| Shay Capital LLC | 0.2% | 205,114 | -13% | 0.09% | $603,035 |
| 683 Capital Management, LLC | 0.19% | 200,000 | -6.9% | 0.05% | $588,000 |
| JANE STREET GROUP, LLC | 0.17% | 176,600 | -54% | 0% | $519,204 |
| GOLDMAN SACHS GROUP INC | 0.15% | 152,952 | -66% | 0% | $449,679 |
| Lakeside Advisors, INC. | 0.11% | 111,101 | 0.22% | $326,637 | |
| WELLS FARGO & COMPANY/MN | 0.1% | 101,971 | +46% | 0% | $299,795 |
| Blue Trust, Inc. | 0.08% | 85,888 | 0% | 0% | $252,511 |
Institutional Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 21,523,954 | $63,555,449 | -$6,062,639 | $2.94 | 79 |
| 2025 Q4 | 23,239,545 | $115,291,318 | +$36,552,641 | $4.97 | 77 |
| 2025 Q3 | 15,541,415 | $48,917,159 | -$26,338,868 | $3.15 | 65 |
| 2025 Q2 | 26,238,674 | $59,299,106 | +$26,395,211 | $2.26 | 64 |
| 2025 Q1 | 14,388,656 | $38,412,610 | -$6,420,566 | $2.67 | 72 |
| 2024 Q4 | 16,340,748 | $57,510,675 | -$2,280,524 | $3.52 | 70 |
| 2024 Q3 | 16,929,998 | $81,217,159 | +$2,394,591 | $4.74 | 64 |
| 2024 Q2 | 12,513,128 | $58,811,518 | +$9,414,756 | $4.70 | 54 |
| 2024 Q1 | 10,495,260 | $47,701,835 | +$35,368,247 | $4.54 | 39 |
| 2023 Q4 | 2,727,493 | $11,236,940 | -$1,729,113 | $4.12 | 29 |
| 2023 Q3 | 3,117,219 | $13,403,691 | -$2,279,792 | $4.30 | 35 |
| 2023 Q2 | 3,562,232 | $18,487,663 | +$5,645,131 | $5.19 | 38 |
| 2023 Q1 | 2,470,554 | $16,600,668 | +$3,392,110 | $6.80 | 31 |
| 2022 Q4 | 1,999,698 | $4,902,826 | -$458,841 | $2.45 | 27 |
| 2022 Q3 | 2,121,733 | $7,001,230 | +$176,107 | $3.30 | 28 |
| 2022 Q2 | 2,043,015 | $9,968,000 | -$109,417 | $4.88 | 31 |
| 2022 Q1 | 1,932,821 | $14,633,000 | -$2,149 | $7.57 | 33 |
| 2021 Q4 | 1,918,795 | $14,925,000 | +$535,636 | $7.78 | 26 |
| 2021 Q3 | 1,782,658 | $15,149,000 | -$1,185,059 | $8.50 | 30 |
| 2021 Q2 | 1,948,272 | $17,498,000 | +$7,592,533 | $8.98 | 28 |
| 2021 Q1 | 1,007,113 | $11,662,000 | +$6,322,912 | $11.58 | 16 |
| 2020 Q4 | 493,003 | $3,994,000 | +$307,274 | $8.10 | 14 |
| 2020 Q3 | 452,590 | $3,789,000 | +$3,789,000 | $8.37 | 12 |